Showing 14,581 - 14,600 results of 34,510 for search '(( 50 ((nn decrease) OR (((we decrease) OR (a decrease)))) ) OR ( 5 point decrease ))', query time: 1.18s Refine Results
  1. 14581

    Evaluation of caries risk reduction following preventive programs in orthodontic patients, using Cariogram computer model: A quasi-experimental trial by Maryam DOOST-HOSEINI (12853424)

    Published 2022
    “…The mean percentage of the “Actual chance of avoiding new cavities” section in the intervention group increased from 45.72 ± 21.64 to 62.50 ± 17.64. However, the mean percentage of other parameters - such as “Diet”, “Bacteria” and “Susceptibility” - decreased after six months (p< 0.001). …”
  2. 14582
  3. 14583
  4. 14584
  5. 14585
  6. 14586

    Quantum Dot Hybridization of Piezoelectric Polymer Films for Non-Transfer Integration of Flexible Biomechanical Energy Harvesters by Haiyan Fu (133503)

    Published 2022
    “…Their specific output voltage and charge density were stably maintained at 7.16 V and 2.40 nC/cm<sup>2</sup>, which were 30.7 and 50.0% higher than those of FPENGs based on a pure piezoelectric polymer film, respectively. …”
  7. 14587

    Quantum Dot Hybridization of Piezoelectric Polymer Films for Non-Transfer Integration of Flexible Biomechanical Energy Harvesters by Haiyan Fu (133503)

    Published 2022
    “…Their specific output voltage and charge density were stably maintained at 7.16 V and 2.40 nC/cm<sup>2</sup>, which were 30.7 and 50.0% higher than those of FPENGs based on a pure piezoelectric polymer film, respectively. …”
  8. 14588

    Quantum Dot Hybridization of Piezoelectric Polymer Films for Non-Transfer Integration of Flexible Biomechanical Energy Harvesters by Haiyan Fu (133503)

    Published 2022
    “…Their specific output voltage and charge density were stably maintained at 7.16 V and 2.40 nC/cm<sup>2</sup>, which were 30.7 and 50.0% higher than those of FPENGs based on a pure piezoelectric polymer film, respectively. …”
  9. 14589

    Presentation_1_Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study.PPTX by Anthi Bouchla (9748362)

    Published 2022
    “…Surprisingly, patients’ RBC-iROS were decreased, a finding possibly related with the increased G6PDH levels in this group, suggesting a possible compensatory mechanism against the virus. …”
  10. 14590

    <i>In Vitro</i> and <i>In Vivo</i> Antifungal Activity of Lichochalcone-A against <i>Candida albicans</i> Biofilms - Fig 5 by Dalia Seleem (2827508)

    Published 2016
    “…<i>albicans</i> enzymes secretion expressed in U/grams of dry weight after treatment with lichochalcone-A at concentrations of 625 μM and 1500 μM: <b>A.…”
  11. 14591
  12. 14592

    Variation law of UCS. by Wenyu Lv (20139458)

    Published 2025
    “…Notably, the attenuation constant λ follows a monotonically decreasing pattern with increasing loading rate. …”
  13. 14593

    Supplementary Material for: Changes in CRP and CA19-9 during Preoperative Oncological Therapy Predict Postoperative Survival in Pancreatic Ductal Adenocarcinoma by Nurmi A.M. (11299035)

    Published 2021
    “…In the Kaplan-Meier analysis, the median survival for patients with CRP remaining at <3 mg/L was longer than among patients with an increased CRP level at ≥3 mg/L (42 months vs. 24 months, <i>p</i> = 0.001). Patients with a CA19-9 decrease >90% or level normalization (to ≤37 kU/L) during preoperative treatment exhibited a median survival of 47 months; those with a 50–90% decrease, 15 months; and those with a <50% decrease, 17 months (<i>p</i> < 0.001). …”
  14. 14594
  15. 14595
  16. 14596
  17. 14597
  18. 14598

    Self-paced combined training alleviated oxidative stress, inflammatory responses and hyperlipidaemia in people living with multiple sclerosis: a randomised controlled trial by Sonda Jallouli (20484146)

    Published 2024
    “…</p> <p><b>Results:</b> Comparatively with CG, the TG showed a decrease in advanced oxidation protein products (p = 0.002, Hedges’g (g) = 1.50) and total thiols (p = 0.0011, g = 1.57), as well as an increase in reduced glutathione (p = 0.03, g = 0.98). …”
  19. 14599

    DataSheet_1_A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor ac... by Zhiyu Huang (638377)

    Published 2023
    “…Background<p>QL1604 is a humanized immunoglobulin G4 monoclonal antibody against programmed cell death protein 1. …”
  20. 14600